within Pharmacolibrary.Drugs.ATC.A;

model A02BX14_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.1,
    Cl             = 8.8 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,
    adminCount     = 1,
    Vd             = 0.0676,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.021666666666666667,
    Tlag           = 13.8
  );

  annotation(Documentation(
    info ="<html><body><p>Rebamipide is a gastroprotective drug used primarily for the treatment of gastric ulcers, gastritis, and the protection of the gastrointestinal mucosa. It acts by increasing the production of mucus and enhancing mucosal defense mechanisms. Rebamipide is approved and used mainly in Japan and other Asian countries.</p><h4>Pharmacokinetics</h4><p>Population pharmacokinetic parameters for healthy adult volunteers using oral administration and a two-compartment model. Values are median estimates from published clinical data.</p><h4>References</h4><ol><li><p>Baek, IH, et al., &amp; Kim, MJ (2020). Interspecies differences on pharmacokinetics of rebamipide following oral administration to rats and dogs. <i>Biopharmaceutics &amp; drug disposition</i> 41(6) 268–272. DOI:<a href=&quot;https://doi.org/10.1002/bdd.2247&quot;>10.1002/bdd.2247</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32557753/&quot;>https://pubmed.ncbi.nlm.nih.gov/32557753</a></p></li><li><p>Shin, BS, et al., &amp; Yoo, SD (2004). Oral absorption and pharmacokinetics of rebamipide and rebamipide lysinate in rats. <i>Drug development and industrial pharmacy</i> 30(8) 869–876. DOI:<a href=&quot;https://doi.org/10.1081/ddc-200034577&quot;>10.1081/ddc-200034577</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15521332/&quot;>https://pubmed.ncbi.nlm.nih.gov/15521332</a></p></li><li><p>Bakulina, NV, et al., &amp; Nekrasova, AS (2023). [Pharmacokinetics and pharmacodynamics of rebamipide. New possibilities of therapy: A review]. <i>Terapevticheskii arkhiv</i> 94(12) 1431–1437. DOI:<a href=&quot;https://doi.org/10.26442/00403660.2022.12.202000&quot;>10.26442/00403660.2022.12.202000</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37167190/&quot;>https://pubmed.ncbi.nlm.nih.gov/37167190</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A02BX14_1;
